Related Experiment Video
Updated: Jul 17, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Delayed presentation of low molecular weight heparin treatment failure in a patient with mitral valve prosthesis
Sotiris C Stamou1, Edward E Lefrak
1Section of Cardiac Surgery, Inova Fairfax Hospital, Falls Church, Virginia, USA. cvsisfun@hotmail.com
Abstract:
We describe a patient who developed right basal ganglion stroke and partial obstruction of St. Jude mitral valve prosthesis as a result of treatment failure with enoxaparin. The patient did not develop the embolic complication from the thrombosis until almost 4 months after the bridging sequence with low molecular weight heparin. The patient underwent thrombectomy of the mitral valve. At least 16 similar cases with mechanical valve prostheses and treatment failure of low molecular weight heparin have been reported.
Related Concept Videos
Mitral Stenosis III: Medical Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse I: Introduction
Venous Thrombosis III: Interprofessional Care
Mitral Valve Prolapse II: Assessment and Management
